Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Lyophilized ACYW135 Meningococcal Conjugate Vaccine
CTR20201077Phase 3Completed
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal conjugate vaccine quadrivalent in meningococcal disease, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Jun 2020; status: completed.
02
Drugs
Meningococcal conjugate vaccine quadrivalent
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on CTR20201077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201077.